Kraig Biocraft Laboratories Inc (KBLB)

[first mike]

As can be expected, the stock price has dropped a bit with the release of the new detailed and exhaustive prospectus.

I have often predicted in the past that for a development stage company it is to be expected that the PPS is negatively impacted each time a 10Q or 10K is released.
The reason for this is that investors who have never done the proper DD on their investment are confronted by all of the Risk disclaimers, Going Concern statements, lack of present revenue, etc, etc. that are required as part of such filings.
Most of us here are all well aware of the risks associated with development stage companies and are not surprised or upset by such statements, (with the exception of certain strident frequent posters) but for the new and unaware investor they are a rude wake up call.

The new exhaustive prospectus has been rewritten to include all of this boilerplate and thus will act much like a 10Q in this respect.
I expect the stock price to be somewhat depressed for about a week or two (or until news if it comes sooner) as various people discover it.

Mike L.